Champions Oncology, Inc. (NASDAQ:CSBR) Q2 2026 Earnings Call Transcript December 15, 2025
Champions Oncology, Inc. misses on earnings expectations. Reported EPS is $0.02 EPS, expectations were $0.08.
Operator: Greetings. Welcome to the Champions Oncology Second Quarter Fiscal Year 2026 Earnings Call. [Operator Instructions] Please note, this conference is being recorded. I will now turn the conference over to your host, Rob Brainin, Chief Executive Officer.
Robert Brainin: Good afternoon,...
